Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 3 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)RecruitingNCT06514794Phase 2
- Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene TherapiesRecruitingNCT06508775Not applicable
- Vitamin A and D Supplementation in Allogeneic HCTRecruitingNCT06508099Phase 2
- TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALLRecruitingNCT06481735Phase 1/2
- Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALLRecruitingNCT06481241Not applicable
- Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALLRecruitingNCT06481228Not applicable
- BeFluBu vs FluBuRux Conditioning in Haploidentical HCTRecruitingNCT06477549Phase 2
- Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)RecruitingNCT06462365Phase 1
- the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic LeukemiaNot yet recruitingNCT06461091
- Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AMLRecruitingNCT06452732
- Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic LeukemiaRecruitingNCT06450067
- Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic LeukemiaRecruitingNCT06446661Not applicable
- CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLRecruitingNCT06445803Phase 1
- Blinatumomab Maintenance After Allo-HSCTNot yet recruitingNCT06438796Phase 2
- The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic LymphomaNot yet recruitingNCT06434467Phase 3
- Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic LeukemiaRecruitingNCT06427330Phase 2
- Brain MRF in Children, Adolescents and Young Adults With Acute LeukemiaRecruitingNCT06421155Not applicable
- Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T CellsRecruitingNCT06420076Phase 1/2
- Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell MalignanciesRecruitingNCT06408194Phase 1
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesRecruitingNCT06398457Early Phase 1
- Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALLRecruitingNCT06393985Phase 2
- Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchRecruitingNCT06393335Early Phase 1
- Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia PatientsRecruitingNCT06392581
- CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell DysfunctionRecruitingNCT06389305Not applicable
- Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALLRecruitingNCT06387121Phase 2
- Haplo-cord HCT vs. Haplo-HCT for T-ALL PatientsRecruitingNCT06381817Phase 3
- Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell LymphomaRecruitingNCT06376721Phase 1/2
- Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain DevelopmentRecruitingNCT06367920
- Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral DensityRecruitingNCT06367725
- Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)Not yet recruitingNCT06367114Phase 2
- Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for LeukemiasRecruitingNCT06364423Phase 1/2
- CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+RecruitingNCT06355739Not applicable
- Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) TrialRecruitingNCT06355583Phase 2
- Early Assessment of Cardiac Function After Treatment With CAR-T CellsRecruitingNCT06350994
- CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHLRecruitingNCT06346912Early Phase 1
- Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL PatientsRecruitingNCT06343090Not applicable
- Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After TransplantationRecruitingNCT06339775Phase 4
- Ma-Spore ALL 2020 StudyRecruitingNCT06336395Phase 2
- Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.RecruitingNCT06334835
- CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological MalignanciesRecruitingNCT06326463Phase 1
- Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical TrialRecruitingNCT06326008Phase 1
- Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart DiseaseRecruitingNCT06325280
- MedSupport Intervention to Identify and Address Barriers to Pediatric Medication AdherenceRecruitingNCT06323044Not applicable
- Technology in Play for Children With Physical Disabilities: the Dice Model of PlayRecruitingNCT06319430Not applicable
- CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell MalignanciesRecruitingNCT06316856Phase 1/2
- Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell MalignanciesRecruitingNCT06316427Phase 1/2
- Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaRecruitingNCT06308588Phase 1/2
- The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic LeukemiaRecruitingNCT06307600Early Phase 1
- VR-PAT and fNIRS to Identify CNS Biomarkers of PainNot yet recruitingNCT06303687Not applicable
- PTCy and ATG for MSD and MUD TransplantsRecruitingNCT06299462Phase 1/2
- Raman Spectroscopy Compared to Flow CytometryRecruitingNCT06291428
- Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaRecruitingNCT06289673Phase 4
- 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic SyndromeRecruitingNCT06287944Phase 1
- A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)RecruitingNCT06287528Phase 1
- Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchRecruitingNCT06277011Early Phase 1
- Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruitingNCT06274788
- Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in KoreaRecruitingNCT06257394Phase 2
- Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)Not yet recruitingNCT06251648
- Pediatric Normative Markerless Movement AnalysisRecruitingNCT06249880
- Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell TransplantationRecruitingNCT06247501Phase 2
- Coagulopathy in Childhood Acute Lymphoblastic LeukaemiaNot yet recruitingNCT06242353
- MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult PatientsRecruitingNCT06237192Not applicable
- Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ MalignanciesRecruitingNCT06227026Phase 1
- A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALLRecruitingNCT06220487Phase 2
- Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).RecruitingNCT06213636Phase 1/2
- INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic LeukemiaNot yet recruitingNCT06209671Phase 1
- A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)RecruitingNCT06207123Phase 1/2
- TGRX-814 Chinese Phase I/II in Patients With Hematological MalignanciesRecruitingNCT06206174Phase 1/2
- Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic LeukemiaRecruitingNCT06184009Phase 2
- CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALLRecruitingNCT06179524Phase 2
- Treatment Protocol for Newky Diagnosed Adult Ph Positive ALLNot yet recruitingNCT06175702
- A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)RecruitingNCT06173518Phase 1
- The Role of NK Cells to Detect Blood Infection in ALL.Not yet recruitingNCT06160115
- Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)RecruitingNCT06144606Phase 2
- CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical StudyRecruitingNCT06136364Phase 1
- Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionRecruitingNCT06131801
- Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeRecruitingNCT06128070Phase 2
- Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing BlinatumomabRecruitingNCT06125106Phase 1
- Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"Not yet recruitingNCT06107478
- Multicenter HomeVENT: Home Values and Experiences Navigation TrackRecruitingNCT06102330Not applicable
- CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and LymphomaRecruitingNCT06101381Phase 1/2
- A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma PatientsNot yet recruitingNCT06087419Phase 1/2
- Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic LeukemiaRecruitingNCT06082934Phase 1/2
- CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic LeukemiaRecruitingNCT06081478Phase 2
- CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).RecruitingNCT06078306Phase 2
- Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3RecruitingNCT06074666Not applicable
- CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LLRecruitingNCT06064903Phase 1/2
- Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCTRecruitingNCT06061094Phase 2
- Thiotepa, Cyclophosphamide, Clarithromycin and CytarabineRecruitingNCT06060782Phase 1
- CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantRecruitingNCT06059391Phase 2
- QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06056752Phase 1
- A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)RecruitingNCT06051409Phase 3
- Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALLNot yet recruitingNCT06050850Not applicable
- Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic MalignanciesRecruitingNCT06037018Phase 1
- Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic LeukemiaRecruitingNCT06034561Phase 2
- Study of VIP943 in Subjects With Advanced CD123+ Hematologic MalignanciesRecruitingNCT06034275Phase 1
- Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INORecruitingNCT06025682
- Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesRecruitingNCT06013423Phase 2
- A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk FactorsRecruitingNCT05963971Not applicable
- Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in BrazilRecruitingNCT05959720